Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature
Apalutamide is a novel nonsteroidal androgen receptor inhibitor that has been shown to improve outcomes for patients with nonmetastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer when combined with androgen deprivation therapy. Apalutamide-induced skin r...
Main Authors: | Calvin R. Flynn, Shun-Chieh Liu, Berbie Byrne, James Ralph, Gabriela Paz, Salman Anwar, Jemma Buchalter, Orla M. Fitzpatrick, Trevor Markham, Paul Donnellan |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/532009 |
Similar Items
-
Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
by: Kana Osawa, et al.
Published: (2022-05-01) -
Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
by: Saizo Fujmoto, et al.
Published: (2023-02-01) -
Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case
by: Fumiaki Kirishima, et al.
Published: (2022-05-01) -
Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
by: Gul A, et al.
Published: (2019-08-01) -
Apalutamide-induced ichthyosiform eruption
by: Christian Ciolfi, et al.
Published: (2023-08-01)